Propanc Biopharma (PPCB) Cost of Revenue (2017 - 2020)
Propanc Biopharma (PPCB) reported Cost of Revenue of $7,591 for fiscal Q3 2020 (quarter ended Mar 31, 2020), up 4.7% from $7,248 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Propanc Biopharma (PPCB) Cost of Revenue (2017 - 2020) Analysis & Trends
Over the twelve months ended Mar 31, 2020, Propanc Biopharma's Cost of Revenue came in at $32,102, up 12.4% year-over-year; for FY2019 (ended Jun 30, 2019), it came in at $28,062, down 8.1% from FY2018.
- By fiscal year, Cost of Revenue came in at $30,521 in FY2018 (+5.3%) and $28,992 in FY2017.
- Five-year quarterly Cost of Revenue spans a low of $6,287 in fiscal Q4 2019 and a high of $10,632 in fiscal Q1 2020.
- Year over year, Cost of Revenue has now increased in each of the last three quarters, with growth averaging 3.2% over the last seven quarters.
- Per Business Quant data, the three fiscal quarters before Q3 2020 came in at $7,592 (Q2 2020), $10,632 (Q1 2020) and $6,287 (Q4 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Propanc Biopharma | 31,463.88 | -1.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 7,591.00 |
| Dec 31, 2019 | 7,592.00 |
| Sep 30, 2019 | 10,632.00 |
| Jun 30, 2019 | 6,287.00 |
| Mar 31, 2019 | 7,248.00 |
| Dec 31, 2018 | 6,449.00 |
| Sep 30, 2018 | 8,078.00 |
| Jun 30, 2018 | 6,787.00 |
| Mar 31, 2018 | 8,005.00 |
| Dec 31, 2017 | 6,899.00 |
| Sep 30, 2017 | 8,830.00 |
API Access
Propanc Biopharma Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();